Overview
Autosomal recessive spastic paraplegia type 74 (SPG74) is an extremely rare inherited neurological condition that primarily affects the nerves controlling leg movement. It belongs to a group of disorders called hereditary spastic paraplegias (HSPs), which are characterized by progressive stiffness (spasticity) and weakness in the legs. In SPG74, the condition is caused by mutations in the IBA57 gene, which plays an important role in how cells produce energy through iron-sulfur cluster assembly in the mitochondria (the energy-producing parts of cells). People with SPG74 typically develop progressive difficulty walking due to increasing stiffness and weakness in the lower limbs. The upper limbs are usually less affected or spared entirely. Some individuals may also experience additional neurological features. The age when symptoms first appear can vary, but it often begins in childhood or early adulthood. There is currently no cure for SPG74. Treatment focuses on managing symptoms and maintaining quality of life. Physical therapy, stretching exercises, and medications to reduce muscle stiffness (such as baclofen or tizanidine) are commonly used. Assistive devices like braces, walkers, or wheelchairs may become necessary as the disease progresses. Because this condition is so rare, much of the understanding comes from a very small number of reported cases, and research is ongoing to better understand the disease and develop new treatments.
Also known as:
Key symptoms:
Progressive leg stiffness (spasticity)Difficulty walkingLeg weaknessIncreased muscle tone in the legsOveractive reflexes in the legsAbnormal gait patternFoot deformities such as high archesBalance problemsFatigue during physical activityPossible bladder control difficultiesPossible mild sensory changes in the feet
Clinical phenotype terms (19)— hover any for plain English
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for Autosomal recessive spastic paraplegia type 74.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Autosomal recessive spastic paraplegia type 74 at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Autosomal recessive spastic paraplegia type 74.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Autosomal recessive spastic paraplegia type 74.
Community
No community posts yet. Be the first to share your experience with Autosomal recessive spastic paraplegia type 74.
Start the conversation →Latest news about Autosomal recessive spastic paraplegia type 74
No recent news articles for Autosomal recessive spastic paraplegia type 74.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.How quickly is this condition likely to progress in my case or my child's case?,What physical therapy program do you recommend, and how often should sessions occur?,Are there any medications that could help with the stiffness and spasms?,Should other family members be tested for carrier status?,Are there any clinical trials or research studies we could participate in?,What assistive devices or home modifications should we consider now or plan for?,Are there other symptoms beyond leg stiffness that we should watch for?
Common questions about Autosomal recessive spastic paraplegia type 74
What is Autosomal recessive spastic paraplegia type 74?
Autosomal recessive spastic paraplegia type 74 (SPG74) is an extremely rare inherited neurological condition that primarily affects the nerves controlling leg movement. It belongs to a group of disorders called hereditary spastic paraplegias (HSPs), which are characterized by progressive stiffness (spasticity) and weakness in the legs. In SPG74, the condition is caused by mutations in the IBA57 gene, which plays an important role in how cells produce energy through iron-sulfur cluster assembly in the mitochondria (the energy-producing parts of cells). People with SPG74 typically develop progr
How is Autosomal recessive spastic paraplegia type 74 inherited?
Autosomal recessive spastic paraplegia type 74 follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.